Experience with Intravitreal Ranibizumab as an Adjunct to Ablation Therapy in Eyes with Exudative Coats’ Disease

References

• Yang X, Wang C, Su G. Recent advances in the diagnosis and treatment of Coats’ disease. Int Ophthalmol. 2019;39(4):957–970. doi:10.1007/s10792-019-01095-8
   Web of Science ®Google Scholar
• Morris B, Foot B, Mulvihill A. A population-based study of Coats disease in the United Kingdom I: epidemiology and clinical features at diagnosis. Eye. 2010;24(12):1797–1801. doi:10.1038/eye.2010.126
   PubMed Web of Science ®Google Scholar
• Sigler EJ, Randolph JC, Calzada JI, Wilson MW, Haik BG. Current management of Coats disease. Surv Ophthalmol. 2014;59(1):30–46. doi:10.1016/j.survophthal.2013.03.007
   PubMed Web of Science ®Google Scholar
• Brockmann C, Löwen J, Schönfeld S, et al. Vascular findings in primarily affected and fellow eyes of middle-aged patients with Coats’ disease using multimodal imaging. Br J Ophthalmol. 2020. doi:10.1136/bjophthalmol-2020-317101
   Web of Science ®Google Scholar
• Shields JA, Shields CL, Honavar SG, Demirci H, Cater J. Classification and management of Coats disease: the 2000 proctor lecture. Am J Ophthalmol. 2001;131(5):572–583. doi:10.1016/S0002-9394(01)00896-0
   PubMed Web of Science ®Google Scholar
• Shields CL, Udyaver S, Dalvin LA, et al. Coats disease in 351 eyes: analysis of features and outcomes over 45 years (by decade) at a single center. Indian J Ophthalmol. 2019;67:772. doi:10.4103/ijo.IJO_449_19
   Web of Science ®Google Scholar
• Adeniran JF, Duff SM, Mimouni M, Lambert N, Ramasubramanian A. Treatment of Coats’ disease: an analysis of pooled results. Int J Ophthalmol. 2019;12(4):668–674. doi:10.18240/ijo.2019.04.23
   Web of Science ®Google Scholar
• He Y-G, Wang H, Zhao B, Lee J, Bahl D, McCluskey J. Elevated vascular endothelial growth factor level in Coats’ disease and possible therapeutic role of bevacizumab. Graefe’s Arch Clin Exp Ophthalmol. 2010;248(10):1519–1521. doi:10.1007/s00417-010-1366-1
   Web of Science ®Google Scholar
• Ray R, Barañano DE, Hubbard GB. Treatment of Coats’ disease with intravitreal bevacizumab. Br J Ophthalmol. 2013;97(3):272LP- 277. doi:10.1136/bjophthalmol-2012-302250
   Web of Science ®Google Scholar
• Liang T, Peng J, Zhang Q, Zhu X, Xu Y, Zhao P. Management of stage 3B Coats disease: presentation of a combined treatment modality and long-term follow-up. Graefe’s Arch Clin Exp Ophthalmol. 2020;258(9):2031–2038. doi:10.1007/s00417-020-04739-z
   Web of Science ®Google Scholar
• Ramasubramanian A, Shields CL. Bevacizumab for Coats’ disease with exudative retinal detachment and risk of vitreoretinal traction. Br J Ophthalmol. 2012;96(3):356–359. doi:10.1136/bjophthalmol-2011-300141
   PubMed Web of Science ®Google Scholar
• Gaillard M-C, Mataftsi A, Balmer A, Houghton S, Munier FL. ranibizumab in the management of advanced Coats disease stages 3B and 4: long-term outcomes. Retina. 2014;34(11):2275–2281. doi:10.1097/IAE.0000000000000248
   Web of Science ®Google Scholar
• Yousef YA, ElRimawi AH, Nazzal RM, et al. Coats’ disease: characteristics, management, outcome, and scleral external drainage with anterior chamber maintainer for stage 3b disease. Medicine (Baltimore). 2020;99(16):e19623. doi:10.1097/MD.0000000000019623
   Web of Science ®Google Scholar
• Daruich A, Matet A, Munier FL. Younger age at presentation in children with Coats disease is associated with more advanced stage and worse visual prognosis: a retrospective study. Retina. 2018;38(11):2239–2246. doi:10.1097/IAE.0000000000001866
   PubMed Web of Science ®Google Scholar
• Park DH, Kim IT. Patient with Parry-Romberg syndrome complicated by Coats’ syndrome. Jpn J Ophthalmol. 2008;52(6):520–522. doi:10.1007/s10384-008-0597-8
   PubMed Web of Science ®Google Scholar
• Nasser O, Greiner K, Amer R. Unilateral optic atrophy preceding Coats disease in a girl with Parry-Romberg syndrome. Eur J Ophthalmol. 2010;20(1):221–223. doi:10.1177/112067211002000132
   PubMed Web of Science ®Google Scholar
• Agarwal A, Pilania RK, Anjani G, Choudhary H, Gupta A, Gupta V. Retinal vasculitis with coats-like response in a young girl with Parry-Romberg Syndrome. JCR J Clin Rheumatol. 2019. doi:10.1097/RHU.0000000000001052
   Web of Science ®Google Scholar
• Ullman S, Danielsen PL, Fledelius HC, Daugaard-Jensen J, Serup J. Scleroderma en Coup de Sabre, Parry-romberg hemifacial atrophy and associated manifestations of the eye, the oral cavity and the teeth: a Danish follow-up study of 35 patients diagnosed between 1975 and 2015. Dermatology. 2020. doi:10.1159/000507925
   Web of Science ®Google Scholar
• Grosso A, Pellegrini M, Cereda MG, Panico C, Staurenghi G, Sigler EJ. Pearls and pitfalls in diagnosis and management of coats disease. Retina. 2015;35(4):614–623. doi:10.1097/IAE.0000000000000485
   Web of Science ®Google Scholar
• Li S, Deng G, Liu J, Ma Y, Lu H. The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat’s disease. BMC Ophthalmol. 2017;17(1):76. doi:10.1186/s12886-017-0469-4
   Web of Science ®Google Scholar
• Mastropasqua R, D’Aloisio R, Stanga PE, Haynes R. Multiple therapy approach for stage 3 Coats disease: long-term follow-up. J Ophthalmol. 2020;2020:8840630. doi:10.1155/2020/8840630
   Web of Science ®Google Scholar
• Nucci P, Bandello F, Serafino M, Wilson ME. Selective photocoagulation in Coats’ disease: ten-year follow-up. Eur J Ophthalmol. 2002;12(6):501–505. doi:10.1177/112067210201200609
   Web of Science ®Google Scholar
• Mrejen S, Metge F, Denion E, Dureau P, Edelson C, Caputo G. Management of retinal detachment in coats disease. Retina. 2008;28:S26–S32. doi:10.1097/IAE.0b013e31816b3158
   Web of Science ®Google Scholar
• Ghazi NG, Al Shamsi H, Larsson J, Abboud E. Intravitreal triamcinolone in Coats’ disease. Ophthalmology. 2012;119(3):648–649.e2. doi:10.1016/j.ophtha.2011.09.059
   PubMed Web of Science ®Google Scholar
• Ong SS, Buckley EG, McCuen BW, et al. Comparison of visual outcomes in Coats’ disease. Ophthalmology. 2017;124(9):1368–1376. doi:10.1016/j.ophtha.2017.03.051
   Web of Science ®Google Scholar
• Ucgul AY, Ozdek S, Ertop M, Atalay HT. External drainage alone versus external drainage with vitrectomy in advanced Coats’ disease. Am J Ophthalmol. 2020;222:6–14. doi:10.1016/j.ajo.2020.09.006
   Web of Science ®Google Scholar